View drug registration information details.
Items | Registration information |
ID | 1631 |
No | 1631 |
Brand Name | ARIMIDEX ANAR |
Ingredients | ANASTROZOLE 1 MG |
Dosage Form | TABLET |
Primary Packaging | BLISTERPACK |
Storage | |
Shelf Life | 2 YEARS |
Pack Size | BOX OF 10 X 10'S |
Dispensing Category | |
ATC Classification | |
Pharmaceutical Class | |
Indications | TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE OR HORMONE RECEPTOR UNKNOWN LOCALLY ADVANCED OR METASTATIC BREAST CANCER, ADJUVANT TREATMENT OF POSTMENOPAUSAL WOMEN WITH HORMONE RECEPTOR-POSITIVE EARLY BREAST CANCER, TREATMENT OF ADVANCED BREAST CANCER IN POSTMENOPAUSAL WOMEN WITH DISEASE PROGRESSION FOLLOW TAMOXIFEN THERAPY |
Contraindications | |
Side Effects | |
Unit Price | |
EDL |
NULL |
Description | WHITE, ROUND TABLETS, PLAIN ON BOTH SIDES |
Note | |
License Owner | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
Manufacturer | LAOS ALLIANCE PHARMACEUTICAL GROUP COMPANY |
Country | LAOS |
Import Registration No | |
Import Registration Date | |
Activity | CERTIFICATE RELEASED |
Applied Date | |
FDD Registration No | 07 L 1131/24 |
FDD Registration Date | 12-JUL-2024 |
Expiry Date | 11-JUL-2027 |
Back to drug list
|